Table I.
Patients' characteristics.
| Categories | n, % |
|---|---|
| n | 67 |
| Median age, years (range) | 68 (44–85) |
| Sex (%) | |
| Male | 82 |
| Female | 18 |
| ECOG PS (%) | |
| 0–1 | 79 |
| 2 | 21 |
| Histology (%) | |
| Adenocarcinoma | 58 |
| Squamous carcinoma | 31 |
| Others | 11 |
| Stage (%) | |
| I | 6 |
| II | 4 |
| III | 48 |
| IV | 42 |
| Postoperative recurrence (%) | 13 |
| EGFR mutation status (%) | |
| Exon19 deletion | 6 |
| L858R in exon21 | 3 |
| Smorking history (%) | |
| Smorker | 84 |
| Non-smorker | 16 |
| Number of prior regimens (%) | |
| 1 | 22 |
| ≤2 | 78 |
| Previous taxane (%) | |
| Yes | 16 |
| No | 84 |
| Median Treatment durations, months (range) | 4.1 (1.0–19.2) |
| Median Treatment cycles, n (range) | 3.6 (1.0–13.6) |